The failure of early pathogen recognition delays initiation of the downstream defense cascade and results in the development of disease symptoms in plants.
In addition, V. shiloi has recently been reported to have stopped infecting its known coral host Oculina patagonica in the Mediterranean Sea [105], suggesting a shift in the 'damage-response framework' [101], defined by Rosenberg et al. [28] as the 'hologenome theory of evolution', i.e., the failure of variant pathogen-host traits to continue producing expected disease signs.
Clinical management of CGD has long been confounded by the relatively high rate of failure of isolating a pathogen from involved sites.
Owing to a rapid colonization of root surface of plants by the BCAs, the failure of pests and pathogens to establish on host helps lessening the severity of diseases that affect roots of plants.
diarrhoea duration: 29 volume of diarrhoea: 29 deaths: 14 duration of pathogen excretion: 16 microbiological failure: 31 clinical failure: 18 volume of rehydration fluids (IV or orally): 24.
Microbiological failure was defined as the persistence of pathogen(s) in laboratory samples or as the development of a new infection.
Intracellular survival of bacterial pathogens determines the success or failure of an infection and bacterial pathogens have evolved to protect their intracellular niche to increase their chances of success.
Persisting nontreponemal antibodies after effective therapy may thus represent failure of immune tolerance rather than lack of pathogen clearance.
We hypothesize that these persistent antibodies are associated with a failure of immune tolerance rather than lack of pathogen clearance after recommended therapies.
The absence of express reference to biological samples is particularly telling in light of the fact that WHO and its member states were, at the time IHR 2005 was being negotiated, aware of concerns about the failure of countries to share samples of pathogens of global concern (e.g., the severe acute respiratory syndrome virus, the influenza [H5N1] virus) for surveillance and other purposes.
The failure of antibiotics to kill various pathogens due to bacterial resistance highlights the urgent need to develop novel, potent, and less toxic agents from natural sources against various infectious agents.
